Analyses of Bcl-2, Survivin, and CD44v6 expressions and human papillomavirus infection in cervical carcinomas

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 5, 2007, Pages 441-448

  Yaqin, M ^a   Runhua, L ^a   Fuxi, Z ^a  

^a Datong University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; PROTEIN BCL 2; SURVIVIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER SCREENING; CANCER STAGING; CARCINOGENESIS; CELL ADHESION; CONDYLOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RATE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADENOCARCINOMA; ADULT; ANTIGENS, CD44; APOPTOSIS; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GLYCOPROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; UTERINE CERVICAL NEOPLASMS;

EID: 34248169764     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540601105772     Document Type: Article

References (28)

1. Pisani, P., Bray, F. and Parkin, DM. (2002) Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer, 97, pp. 72-81.
2. Pilch, H., Gunzel, S., Schaffer, U., Tanner, B., Brockerhoff, P. and Maeurer, M. (2001) Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer-free pelvic lymph nodes: Correlation with clinico-pathological parameters and prognostic significance. Zentralbl Gynakol, 123, pp. 91-101.
3. Rolon, PA, Smith, JS, Munoz, N., Klug, SJ, Herrero, R. and Bosch, X. (2000) Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer, 85, pp. 486-491.
4. DeFilippis, RA, Goodwin, EC and DiMaio, D. (2003) Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virology, 77, pp. 1551-1563.
5. Isacson, C., Kessis, TD, Hedrick, L. and Cho, KR. (1996) Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res, 56, pp. 669-674.
6. Nair, P., Nair, KM, Jayaprakash, PG and Pillai, MR. (1999) Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection. Pathol Oncol Res, 5, pp. 95-103.
7. Takeuchi, S., Ohara, N. and Maruo, T. (2003) Paradoxically abundant expression of Bcl-2 and adrenomedullin in invasive cervical squamous carcinoma. Int J Clin Oncol, 8, pp. 83-89.
8. Frost, M., Jarboe, EA, Orlicky, D., Gianani, R., Thompson, LC and Enomoto, T. (2002) Immunohistochemical localization of Survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol, 117, pp. 738-744.
9. Costa, S., Terzano, P., Bovicelli, A., Martoni, A., Angelelli, B. and Santini, D. (2001) CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. Gynecol Oncol, 80, pp. 67-73.
10. Tokumo, K., Kodama, J., Seki, N., Miyagi, Y., Yoshinouchi, M. and Kudo, T. (1998) CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer. Eur J Cancer, 34, pp. 2107-2111.
11. Baay, MF, Quint, WG, Koudstaal, J., Hollema, H., Duk, JM and Burger, MP (1996) Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol, 34, pp. 745-747.
12. Bosch, FX, Lorincz, A., Munoz, N., Meijer, CJ and Shah, KV. (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, pp. 244-265.
13. Koromilas, AE and Matlashewski, G. (2001) Control of interferon signalling in human papillomavirus infection. Cytokine Growth Factor Rev, 12, pp. 157-170.
14. Bosch, FX, Manos, MM, Munoz, N., Sherman, M., Jansen, AM and Peto, J. (1995) Prevalence of human papillomavirus in cervical cancer: A world perspective. J of the National Cancer Inst, 87, pp. 796-802.
15. Blankenberg, FG. (2004) Recent advances in the imaging of programmed cell death. Curr Pharm Des, 10, pp. 1457-1467.
16. Johnson, MI, Robinson, MC, Marsh, C., Robson, CN, Neal, DE and Hamdy, FC. (1998) Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: Relationship with apoptosis and proliferation. Prostate, 37, pp. 223-229.
17. Arai, T. and Kino, I. (1995) Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol, 176, pp. 37-44.
18. Zanotti, S., Fisseler-Eckhoff, A. and Mannherz, HG. (2003) Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma. Gynecol Oncol, 89, pp. 376-384.
19. Dimitrakakis, C., Kymionis, G., Diakomanolis, E., Papaspyrou, I., Rodolakis, A. and Arzimanoglou, I. (2000) The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol, 77, pp. 129-136.
20. Knowlton, K., Mancini, M., Creason, S., Morales, C., Hockenbery, D. and Anderson, BO. (1998) Bcl-2 slows in vitro breast cancer growth despite its anti-apoptotic effect. J Surg Res, 76, pp. 22-26.
21. Gianani, R., Jarboe, E., Orlicky, D., Frost, M., Bobak, J. and Lehner, R. (2001) Expression of Survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol, 32, pp. 119-125.
22. Kim, HS, Shiraki, K. and Park, SH. (2002) Expression of Survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res, 22, pp. 805-808.
23. Tamm, I., Wang, Y., Sausville, E., Scudiero, DA, Vigna, N. and Oltersdorf, T. (1998) IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anti-cancer drugs. Cancer Res, 58, pp. 5315-5320.
24. Saitoh, Y., Yaginuma, Y. and Ishikawa, M. (1999) Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol, 15, pp. 137-141.
25. Branca, M., Giorgi, C., Santini, D., Bonito, L Di, Ciotti, M. and Costa, S. (2005) Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol, 124, pp. 113-121.
26. Darai, E., Walker-Combrouze, F., Benifla, JL, Henin, D., Feldmann, G. and Madelenat, P. (2000) E-Cadherin and CD44 expression in cervical intraepithelial neoplasia: Comparison between HIV-positive and HIV-negative women and correlation with HPV status. Gynecol Oncol, 76, pp. 56-62.
27. Biesold, C., Kohler, U., Horn, LC, Bilek, K., Kade, R. and Emmert, C. (1995) CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma: An immunocytochemical study of 94 cases. Arch Gynecol Obstet, 256, pp. 147-153.
28. Ahmed, MI, Salahy, EE, Fayed, ST, El-Hefnawy, NG and Khalifa, A. (2001) Human papillomavirus infection among Egyptian females with cervical carcinoma: Relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem, 34, pp. 491-498.